Prevacus Partners with BrainScope for Upcoming Drug Study on Concussion

TALLAHASSEE, Fla., May 18, 2018 /PRNewswire/ — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders today announced a partnership with BrainScope for use of their FDA-cleared BrainScope One device in Prevacus’